We have investigated the effects of five peroxisome proliferators (PPS: clofibric acid, DEHP, WYI4,643, nafenopin, and LY171883) on the abundances of a large number of proteins in the livers oltreai:ed mice at 5-and 35-day time points. LY171883 was investigated at a range of doses, and one of its close structural analogs that is not a peroxisome proliferator (LY163443) was included as a negative control compound. Liver samples were analyzed by quantitative 2-D electrophoresis. Data for a selected set of 107 liver protein spots that respond strongly to at least one of the test compounds was subjected to principal component analysis to search for global protein pattern changes. The first component (PC]L) accounted for 51% of the total data variance and was identilied as a global measure of peroxisomc prolifcration by its correlation with enzymatic peroxisornal /3-oxidation.
We have investigated the effects of five peroxisome proliferators (PPS: clofibric acid, DEHP, WYI4,643, nafenopin, and LY171883) on the abundances of a large number of proteins in the livers oltreai:ed mice at 5-and 35-day time points. LY171883 was investigated at a range of doses, and one of its close structural analogs that is not a peroxisome proliferator (LY163443) was included as a negative control compound. Liver samples were analyzed by quantitative 2-D electrophoresis. Data for a selected set of 107 liver protein spots that respond strongly to at least one of the test compounds was subjected to principal component analysis to search for global protein pattern changes. The first component (PC]L) accounted for 51% of the total data variance and was identilied as a global measure of peroxisomc prolifcration by its correlation with enzymatic peroxisornal /3-oxidation.
Component PC2 (7%) separated 5-and 35-day exposures, and PC3 (5%) separated groups treated with LY163443 from the rest. We used PCI as a surrogate for equivalent dose in order to examine the effects of diverse compounds, with widely differing potencies, on a common scale. Analyzed in this way, the data indicate that all the peroxisome proliferators tested produce effects over wide time and dose ranges that fall on or near a single curve. Examination of specific protein responses showed that many proteins individually show a unified response curve, but that curves for different proteins were different. In particular, it appears that some constitutive proteins showing modest inductions with a high dose plateau (such as cytosolic epoxide hydrolase) are inducible at lower doses than some proteins showing very strong, nonplateaued inductions (such as the 80-kDa peroxisomal hifunctiorial enzyme)-The results provide support for a unified receptor-based mechanism controlling the main PP response, but demonstrate that individual responsive genes can show quite different dose-response curves. © 1996 Academic Press, Inc.
Peroxisome proliferation occurs in the livers of rodents in response to the administration of a range of compounds, iocluding hypolipidemics, plasticizers (Reddy and Lalwani, 1983) , and leukotriene receptor antagonists (Eacho ci al., 1986) . While the associated short-term effects are reversible, chronic treatment with peroxisome proliferators (PPs) induces liver tumors (Reddy and Lalwani, 1983; Bendele et aL, 1990) , leading to the classilication of such compounds as uongenotoxic carcinogens.
The nature of the effect is complex. It involves changes in the abundance of large sets of liver proteins observable u.sing two-dimensional electrophoresis (Watanabe et 0!., 1985; Giometti ci aL, 1991 a,b; Witzmaon et a!., 1994) and thus must involve the differential regulation of many genes. While only a few of the affected proteins have been ideutilied, at least some, and probably a majority, are nonperoxisomal. This result in turn suggests that the phenomenon called peroxisome proliferation involves a diverse series of metabolic changes in liver cells.
Abundant eĩdeace now exists that the main tl'igger for peroxisome proliferation involves binding of PP to one of several peroxisome proliferator-activared receptors (PPARs), ligand-activated transcription factors of the steroid hormone receptor superfamily. In the mouse, at least three such receptors have been sequenced: mPPAR a (Isseman and Green. 1990; Gearing ci aL, 1994) , mPPAR /3 (Amri et aL, 1994) , and mPPAR ')' (Chen ci aL, 1993; Zhu eta!., 1993) , though comparative evidence on xenopus, human, and rodeot PPAR genes suggests that at least five subfamily members exist (Chen ci (IL, 1993) -PPARs appear to form dimers with the retinoid X receptor (Gearing ci a!., 1993; Isseman ci aL, 1993) , and the activated complex binds to specific peroxisome proliferator response elements (PPREs) located upstream of a series of genes including the first two enzymes of the peroxisomal system: fatty acyl-CoA oxidase (ACO; Tugwood ci aL, 1992) and enoyl-CoA hydratase/3-hydroxyacyl-CoA dehydrogenase bifunctional enzyme (PBE: Bardot ci (IL, 1993) . Evidence is accumulating that fatty acids, as well as PP, bind to these receptors (Issernan ci aL, L993b: Banner et (IL, 1993) , suggesting that the PPAR regulatory system normally functions to control fatty acid metabolism. At least one similar human receptor (hPPAR) has been shown to be capable of transactivating PPRE-contnining reporter constructs (Sher ci (IL, 1993) , raising the possibility that PP may produce gene regulation effects in human liver.
While PPAR regulation offers a very attractive mechanism for coordinate control of the PP response, its general validity must rest on an examination of the regulatory behavior of a broad range of liver proteins. Indeed earlier 2-D electrophoretic studies by Giometti (Giometti eta!., 199 la, b) were interpreted as suggesting that different PP produced substantially different effects, which would limit the applicability of a unified PPAR regulation system and point to distinct regulatory pathways influenced by individual PP. Hence we were particularly concerned in this investigation to test the validity of this view using a larger series of PP and what we believe to be an improved statistical approach. Do most PP-affected proteins show regulation consistent with a single, unified receptor-based mechanism? Do structurally varied PPs produce effects consistent with such a mechanism? We believe the answer to be affirmative in both cases, but in the course of the investigation have demonstrated that individual proteins can show quite varied dosereponse curves within the overall unified PP response.
MATERIALS AND METHODS
Animal dosing, tissue preparation, and enzyme njeas,,rements. In the first experiment, 14 groups of 6 male B6C3FI mice received either control diet or diet incorporating the following PPs for either 5 or 35 days before necropsy: 0.30% LYI7III3, 0.30% LY163443, 0.50% clofibrie acid, 0.01% WY 14,643, 0.05% Narenopin. or 0.60% di(2-ethylhexyl)phthalate (DEHP). In a sceond experiment, male B6C3FI mice received LYI7 I 883 at dietary concentrations of 0, 0.003, 0.0!, 0.03. 0.10. 0.30, and 0.60% for 5 days (5 animals in each of the 7 groups). At necropsy, a portion of the liver was homogenized in an eightfold excess (w:v) of 9 M urea, 2% NP-40, 2% ampholytes (pH 9-I I, LKB Inc.), and 0.5% dithiothreitol. A second portion was collccted and the 150-g supernatant assayed for peroxisoma! fl-oxidation as the cyanide insensitive reduction of NAD~using 50 mt~spalmitoyl CoA as substrate (Lazarow. 198!) .
Two-dimensional electrophoresis.
Sample proteins were resolved by 2-fl electrophoresis using Ihe 20 x 25-cm ISO-DALT 2-fl gel system (Anderson and Anderson, l978a,b; Anderson et aL 1994; Hoefer Instruments, Inc.) . Isoelectric focusing (tEE) or nonequilibrium pH gradient electrophoresis (BASO) first dimensions were used to resolve acidic-neutral and basic proteins. respectively. All IEF gels were prepared using a single standardized batch of ampholytes (BDH 4-IA) and the gels were run for 33,000 to 34,500 V-hr. First dimension BASO gels use wide-range Servalyte and a focusing time of 5000 V-hr. Ten ro 20 p1 of solubilized protein was applied to each gel.
Second dimension gradient SOS slab gels were prepared using an Angelique computer-controlled gradient casting system (Large Scale Biology Corp.). Each gel was identified by a computer-printed filter paper label polymerized into the gel. First dimension lEE tube gels were loaded directly onto the slab gels without cquilibration and held in place by potyester fabric wedges. Second dimension slab gels were run in groups of 20 in DALT tanks thermostatted at lOt.
Following 5135 electrophoresis, slab gels were stained for protein using a colloidal Coomassie blue 0-250 procedure in covered plastic boxes, with tO gels per box. This procedure involves fixation in 1.5 liters of 50% ethanol/2% phosphoric acid overnight, three 30-mm washes in 2 liters of cold deionized water, and transfer to 1.5 liters of 34% tnethanolll7% ammoniom sulfate/2% phosphoric acid for I hr followed by addition oil g of powdered Coomassie bLue 0-250 stain. Staining required approximately 4 days to reach equilibrium intensity.
Data analysis. Stained 2-fl gels were digitized in red light at 133-pm resolution using an Eikonix 1412 scanner, and the resulting images processed using procedure PROCOOSb within the Kepler 2-D software system (Large Scale Biology Corp.). This procedure makes use of digital filtering. mathematical morphology techniques, and digital masking to remove background and uses full two-dimensional least-squares optimization to refine the parameters of a 2-fl Gaussian shape for each protein spot, yielding a spotlist giving position, shape, and density information for the detected spots. Spot volumes, measurements of integrated Coommassie blue binding, and hence of protein abundance were calculated from these parameters and expressed in units of pixel-gray levels.
Two experiment packages (PEROXI-435 and PEROX-DOSES I) were constructed using the Kepler experiment definition database to assemble the 14 end 7 groups of IEF/SDS 2-fl patterns corresponding to the groups of treated and control animals in the first and second experiments, respectively. Subsequently, an automatic program matched additional spots to the master pattern using as a basis the manual landmark data entered by the operator.
The operator subseqtmently inspected matching for spots considered i'm portant to the experiment.
The groups of gels nsaking up an experiment were scaled tugclher (to eliminate quantitative differences dtie to gel loading or staining differences) by a linear procedure based on a selected sct of spots. These had spot volumes between 500 and 15,000 pixel-gray levels, and nonclongated shapes (ratio of major to minor axis <2), were present on at least 33 or 35 gels and did not appear to vary in abundance with drug dose. In PEROX-DOSES I, for example, scaling was based on 106 spots, and scale factors ranged betwecn 0.75 and 1.78. After sealing, the number of spots showing inlragroup CV C 0.15 ranged from 152 to 206 spots over he five groups.
A set of protein spots was seleeled on the lEE/SOS gels of the multieonipound sludy as represenLing the protcins most strongly affected in he experiment. This set fulfilled the following criteria, implemented in the Kepler vector system: group average abundance changed away froni the appropriate control value in the same sense (increase or decrease) in all treated grotips; at least one PP-treated group showed a p < 0.00! difference from appropriate controls at each time point; and each spot wa,s present on most gels (present in all but one gel of all but two of the experimental groups and present in all but two gels of all groups). To this set nt 100 proteins were added seven spots representing proteins either induced from undetectable levels and hence excluded from the automatically selected group or showing large changes that did not achieve the general level of statistical significance required. The resulting 107 protein spots can be taken as showing some demonstrable abundance change with respect to controls, though they are by no means all of the proteins affected.
Multirariate statistical analysis. Principal components analysis was undertaken using PROC FACTOR (method = principal) within the SAS software system (SAS Instittite) using data for all 107 selected 1FF/SOS gel spots in the 110-gel multidrug experiment, where any missing data were filled wilh the group average value. The resulting scoring coefficients were saved and applied to the gel data from the second, dose-response experiment so as to obtain comparable estimates of principal component scores for gels from both experiments. I'ro (ej,, .veqIae,Ici,Ig . Protein spois were cut from wet, Coomassie bltiestained 2-fl gels antI subniittcd In internal tryptic digestion (Rosenfeld err!., 992) . Indivitloal peptides separated by HPLC were sequenced using a Perknn-Elmer 477A sequcntrlor.
Clofibric Acid

RESULTS
Protein Changes in Lit~er following Peroxiso,ne
Proliferator Treatment Five PP were investigated: clofibric acid, DEHP, WY14643, nafenopin, and LY171883 (Fig. 1) . LY163443, an analog of L'Y171883 that is not a PP (Eacho eta!., 1989) , was included as a negative control. Treatment effects were measured in sLx animals per group at 5-and 35-day time points using two-dimensional electrophoi'esis, and quantitative abundance data were collected for several hundred proteins (Table 1) . Among the proteins measured, 102 met critena for reliably detected signilic-ant quantitative change (t test p < 0001 for at least one compound with protein detected on almost all gels). Five additional spots that showed strong effects just beyond the limits used for automatic selection wet-c added. T]-se resulting set of 107 proteins are indicated in Fig. 2 on a standard 2-D protein pattern of mouse liver.
Nine additional very basic proteins were selected from among those showing treatment related change.s on BASOtype 2-D gels, including the 80-kDa bifunctional enzyme (PBE).
Mtiltiwp-iate Statistical Analysis
Given the complexity of these gene expression changes, we attempted first to determine whether one overall pattern of change (the same for all compounds, doses, and tinles of treatment, apart from a simple scale factor) could account for a significant proportion of the variation observed. This wa,s accomplished by means of a principal component analysis (PCA) applied to abundance data on the set of 107 protein spots selected from the IEF/SDS 2-D gels. PCA is a multivariate statistical technique that automatically extracts a series of mutually independent patterns from a table of many variables (here the protein spot abundances) measured on many samples (here representing the livers of individual animals). For simplicity, each protein abundance is expressed in terms of its difference from the average value over a!! samples alid the magnitude of the difference is normalized by dividing it by the standard deviation (SD), again over all samples. Hence each sample is characterized by a Relative Change Data on SpottEF:222 3.8(1) 1.2 1.5 1.5 1.4 1.7 1.5 4.3(1) 1.0 1.6 1A 1.4 1.6 1.9 2.5(0) 1.5 1.4 1.3 1.6 1.5 2.5 SpotlEF:259 2.1 (1) 18A(1) 1.5 1.7 2.0 2,1 2.4 2.5 19,5(19) 1.6 1.6 2A 2.1 3.5 2A 35.7(6) 0.8 0.9 1.2 1.2 1.5 1.8 SpotEASO:272 1.6(1) 11 1.6 1.3 1.7 2.6 1.9 21(2) 0.7 1.5 '1.3 1.6 1.6 1. series of protein measurements describing its difference from overall average values. In effect, the PCA procedure extracts first the predominant pattern of differences (PCi), which might involve, for example, a 1.2 SD increase in protein I, a 0.5 SD decrease in protein 2, a 5.8 SD increase in protein 3, etc., and gives a measure of how much that pattern applies to each sample (the sample's PCI score). Then this pattern of change is removed, and the second most important pattern, unrelated to the first, is extracted, and so on. By plotting each sample, or group of samples, on axes expressing their scores on PC! vs P02, for example, it is possible to summarize the similarities and differences among samples with respect to complex patterns of changes in many variable.s (Fig. 3) . Samples that fall near one another on such plots show similar patl:erns of change, while those that are far apart are less similar. The procedure also yields a measure of the relative importance of each of the succeedingly smaller pat(erns of difference, expressed as the percentage of the total data variance explained by that component. The result of our PC analysis of data on 107 protein.s indicates that 51% of the total data variance i.s accounted for by a single component of change (the first principal component-PCI). This component separates the treatment groups in the experiment in a manner that might be expected for a global measure of potency as a PP (Fig. 3 ). Sample.s from animals treated with the negative control compoond LY 163443 (b and B in the plot) lie at positions near the control samples (a, A) with respect to the y-axis (PCI), while samples from animals treated with strong PPs (nafenopin and WY14643; g, C and f, F) lie far away from the controls. This conclusion was tested by plotting the average scores on PCI associated with the 14 treatment and control groups in the si x-conipound experi riient against independent groupaveraged enzymatic measurements of peroxisomal fl-oxidation (Fig. 4) . A strong relationship is observed between the global measure (PCI score) and the specific assay of a single enzyme, although the curve shows possible divergence from a linear relationship in the low effect region. LY163443, which is not a PP, shows only a small effect using either measure. Five-day exposure groups show systematically lower levels of PP effect by both measures when compared to the 35-day exposure groups for the same compounds.
Additional, smaller independent components of change were also detected in the principal component analysis: P02 and PC3 account for 6.7 and 5.0% of the total variation, respectively. PC2 appears to distinguish the 5-and 35-day exposure groups by characteristics independent of their differences on PCI. P03 serves mainly to separate the groups treated with LY163443 from both the controls and the other treatment groups. A detailed examination revealed that LY)63443 causes a series of protein changes unrelated to peroxisome proliferation; one that is apparently unique among compounds so far examined (to be described elsewhere). P04 accounts for only 3.5% and PC5 an additional 2.9% of the data variance, with further components further decreased.
Dose -Response Effects
Differences between the effects of various PP.s could be due to different relative potencies (and hence different levels of effect at the doses chosen), to time-varying effects, or to real differences in the nature of the biological effect produced. The issue of relative potency, in particular, must be taken into account because it is practically impossible to choose dose levels for different compounds that produce exactly the same degree of peroxisonle proliferation. We therefore carried out a conventional dose-response study with a single compound (LY 171883) at six doses to see whether the results would he consistent with a single pattern of change scaled by sonic function of dose, and thus with the assumption that the observed differences between coInpounds could he explained on the basis of relative potency. After a 5-day treatment, group average values of fl-oxidation and PCI score (computed using the same scoring coefficients used in the earlier six compound comparison) both showed monotonic dose-response curves (Fig. 5) . Comparing these two measures against one another (as plotted in Fig. 4) , the dose-response curve for LY 171883 appears consistent with the curve describing the data for all the PPs examined. In Figs. 4 and 5, there is evidence that the PCI score rises more rapidly in the low-effect range than does the fl-oxidation measurement. 'This behavior suggests that SOITiC proteins contributing to the PCI score may show stronger effects at lower dose than do the enzymes of fl-oxidation.
Magnittide croci Pu! anti of' PP-bzth,ced Changes in
Sjẽ~-ifzeProtei,ts
A few proteins, including the 80-kDa bifunctional enzyme, show measured inductions of greater than 50-fold, while some others are induced from normally undetectable levels and could show even stronger relative increases. Nevertheless mosi of the significant protein abundance changes resulting from PP treatment are less than 2-fold (Table 1) .
Of the 107 proteins selected as showing some response to at least one PP in the six-compound study, a significant number showed treatment related decreases instead of inductions. For example, nafenopin at 5 days (group ''g'') de- •t~0 creases a total of 52 of the 116 protein spots and increases 64. Hence the numbers of pfoteins increased and decreased are fairly equally balanced, despite the fact that the net effect is a global increase (since IS proteins are increased by more than twofold, while only S are reduced by more than twofold). Since the data from different gels was normalized together using a subset of protein spots that did not include the 107 main PP-responsive spots, the ratio of increases to decreases should be unaffected by the net effect of PP on total liver protein abundance. In order to examine the behavior of individual proteins across the various experimental groups in the compound comparison and dose-response studies, we elected to plot each protein's group average protein abundance versus the group average scot-c on PCI (which we believe is likely to represent the best estimate of the level of PP response). The plot thus relates protein amount to peroxisome proliferation, with plotted symbols representing the average for a treatment group, Figure 6 shows such plots for the eight protein spots showing the largest positive contributions to the calculation of PCI (the proteins most strongly conelated with PP) and the eight spots showing the largest negative such contributions. The purpose of these plots is to allow detection of treatments (experimental groups) whose effect departs signilicantly from the trend expected for peroxisome proliferation generally. For these proteins, and for most of the others less strongly associated with PCI (and hence with peroxisome proliferation), we did not detect major departures from the trend.
A few proteins, particularly those strongly associated with principal components 2 and 3, did show outlying groups (Fig. 7) . in the case of PC2, the groups representing 35-day treatments are generally clustered away from the 5-day PC3, the outliers are treatment groups, while in the case of the 5-and 35-day groups treated with LY163443.
Shapes of Response Curves
Differences were detected between the dose-response curves of individual proteins in the muitidose study of LY 171883. Some proteins, such as spots LEF:22 (cytosolic epoxide hytirolase), 1FF: ISO, and IEF:239 show evidence for inducti on at low dose Followed by a plateau ttt higher dose. This contrasts with the behavior of the peroxisotlial bifunctiooal euzynie (spot B ASO:76) and IEF: 163 (Fig. 8) , which arc induced from almost ttndetectable endogenous levels and continue to increase without plateati in the dose range studied. 'The same effect is apparent when these proteins are compared over the larger data set covering six compounds at two time points. Since 1FF: 163 is induced by PP more strongly than any other protein in the acidic to neutral p1 range, we attempted to identify it through sequence analysis of 2-D gel-derived material. Data were obtained for two tryptic peptides having sequences DAGGELNLAR and FIPUER, but these did not match any known proteins in current sequence databases. We therefore conclude that at least one protein very strongly responsive to PP is novel.
DISCUSSION
We have examined the effects of peroxisome proliferation in mouse liver with respect to a series of variables: dose, time of exposure, PP ttsed, and protein markers analyzed. The results support the contention that peroxisonie prolifeiation is a complex phcnomenon at the biochemical level, involving more than 100 proteins, but one that can nevertheless be largely atiributed to a single coherent gene regulation pattern affecting many proteins in a coordinated way. This pattecn of gene expression change chanacteristic of peroxisonie proliferation was extracted through the use of principal component analysis, a multivariate statistical technique that uncovers a series of mutually independent patterns of change (components) that explain most of the variation occurring in the variables analyzed (here protein abtindances).
Each component consists of a set of coefficients for each of the proteins measured and a sum of the protein abttndances weighted by these coefficients gives an aggregate measure eqtsal to the score of the sample concerned for that component. The effect is to reduce the complexity of the data from a picture consisting of 107 separate and independent protein measurements to a picture consisting of a few components, each of which describes in a unified way changes occurring in many proteins at once. The first (and by definition largest) component in our analysis of 107 proteins measured in 14 groups of 6 animals accounted for more than 50% of all the variance in this large data set, with the second and third inde- Because random protein measurement errors arising from measurements, it is typical that only a few of the largest the 2-D gel procedure, as well as random interanimal differ-principal components relate to experimental treatments, ences irs protein levels, contribute to the variation in protein while the remainder represent "noise'' in the measurements. In this case, the 51% attributable to a coordinated PP effect (PCI) is a remarkably large fraction. Its size demonstrare.s that peroxison]c proliferation was the largest influence in the study by far, leaving little root]] for major differences among the compounds and conditions tested.
If the Iirst compotletit (PCI) is indeed a global measure of peroxisonie proliferation, it shotnid correlate reasonably well with enzymatic meaSurements of peroxisomal /3-oxidation, a characteristic inducible feature of the PP effect. A strong relationship wa,s indeed found between these indices over all the compounds, time points, and doses tested, indicating that PCI is a general measure of the gene expression changes caused by PP. Interestingly, the relationship between PCI and /3-oxidation is not entirely linear, especially at low dose, and this raises the possibility that the PP response includes aspects that do not follow the same doseresponse curve as the enzymes of /3-oxidation. Since PCI is based on a combination of measurements of a large number of proteins, we decided to use it instead of /3-oxidation as an index agait]st which we could compare the responses of individual proteins.
When the group-averaged abundatices of specific proteins were plotted against the average PCI scores for those groups (a plot of speci6c vs overall protein response), we found thai all the treatment groups fell on or near a consistent curve for many proteins. Thus for these proteins, all the PP compounds produce effects at either 5 or 35 days that together approximate the effects of one compound at a range of doses. Data from the true dose-response curve of one compound, LY171883, also falls near this curve, reinforcing this view. The existence of a smooth relationship of this type, at least for some proteins, is consistent with direct gene expression control via a unified PP receptor mechanism. By selecting proteins that demonstrate such a response over a series of structurally diverse peroxisome proliferators, at different time points and doses, we have identified a core group of gene products that define the 'homogeneous'' PP response in mice. As it happens, some of these changes were detected earlier in a study not directed at peroxisome proliferation, where high doses of ibuprofen were found to produce a specific effect not interpretable at the time (Anderson et at. 1987) , but now recognizable as the core PP effect.
It is clear ftum the detailed behavior of these PP-responsive proteins that a simple induction picture of the effect is not adequate. While the peroxisomal enzymes, typified by the 80-kDa bifunctional enzyme (PBE; spot BASO:76), demonstrate very large inductions and thus dominate the effect in Lert-ns of protein mass, almost halfof the responsive proteins show decreased abundance after treatment rather than induction. This result contrasts with the aggregate mlpression prodit ced by most previously reported PP regulatory effecls; these oredon-sinantly involve upregulation, althotigh BiP/GRP78 has been reported to decrease (Motojima and Goto, 1992) under some circumstances, while increasing in others (WitzlTtann et at, 1994) . At this stage we do not know whether the downregulated genes observed here are regulated in a negative sense by PPAR (the m'cccptor associated with marty of the strong inductions) or whether there is a cascade of linked mechanisms that reduce expfession of some proteins as a secondary response following major PPAR-controlied inductions. Evidence from the rat suggests that a major PP-responsive protein (rat IEF:367) also shows anti-synergistic regulation by the cholesterol-lowering treatn]ents lovastatin and cholestyramine (Anderson et at, 1991, and unptnhlished observations It is evident from these differences in the response curves of different proteins that specific biochemical effects of PPs could show highly nonlinear dose-response relationships.
If, for example, sonle in]portant biochemical event were influenced by the relattve abundance of cEH and PBE, then the low-dose induction of eEl-I (where PBE is effectively uninduced) could lead to one outcome, while at higher doses (where cEH induction is plateaued. while PBE is rapidly increasing) an inverse otttcome could occur. Thu.s it is possible, based on our results, that the low-dose and high-dose effects of PPs could he qualitatively different. A definitive resolution of this isstte awaits a com-npiete analysis of the binchetiiistry of peroxisome proliferation and identification of all the affected 2-D gel spots. Both overall anti specific protein effects on PCI were generally larger after 35 days than after 5 days of exposure, for all PP examined. This Contrasts with effects on cell replication, which are generally greater at 5 days than 35 (data not shown), and suggests [hat the protein changes observed on component I are not related directly to rates of cell division. PC2, the second largest component of change detected, separates the 5-and 35-day time points for all compounds tested, a.s well as for the controls. At present, the interpretation of this pattern of change is ambiguous: it could reflect adaptive gene expression changes following extended treatment, an]d thtts may be of ititerest with respect to tumorigenesk. Alternatively, it could represent contributions associated with differences in aninial cohorts or husbandry or differences in the 2-D analytical system over time (sinace the gels for the 5-and 35-day groups were not run at the same time). Finally, and we believe most likely, it could represent differences dtte to anisiial age: because the animals were relatively young at the start of the six-compound study, an additional 30 days of age in the 35-day groups could have a significant systematic eft'ect. Earlier studies have shown evidence for significant protein changes in male mouse liver over the range of 5 to 10 weeks of age (C. S. Giometti, personal communication) .
Principal component 3 appears to be almost entirely a reflection of the effects of one compound-LY163443. This compound is a structural analog of the potent PP LY171883 (Fig. 1) and has the same pharmacologic activity (as a leukotriene receptor antagonist), but is not itself a proliferator and thus shows minimal difference from controls on PC1. The results on PC3 demonstrate, however, that LY163443 produces protein abundance alterations not shared with the PPs. These include both increases and decreases, as well as apparent charge modification of one protein (recently identified as fumarylacetoacetase by partial amino acid sequence analysis) that may be due to covalent adduct formation (details to be described elsewhere). The existence of such a component demonstrates unequivocally that the analytical approach used can not only measure the PP effect but resolve it from other, unrelated protein changes based on multiparameter protein abundance data.
The differences we observed between dose-response curves for various proteins may provide at least a partial explanation for the difference between our conclusions and those advanced by Giometti et at (199 Ia, b) regarding the heterogeneity of liver protein responses to a series of PP. Giometti found only 19% of data variance to be explained by a component (PC2 in their case) likely to be the primary PP effect in a similar experiment and also reported that many individual proteins showed differences in levels of change caused by a series of PPs at a single dose and time point. This picture suggests that differences among PP are relatively large compared to the underlying similarities and hence that the currently accepted receptor-mediated mechanism may have a very limited power to explain the actions of structurally diverse PP. Our results suggest, on the contrary, that a large majority of the quantitative changes caused by all the PP examined result from operation of a single unified mechanisnr Our results on the different dose-response curves shown by different proteins suggest an explanation for this apparent contradiction. Since Giometti used single doses and ti]rne points for each compound, and since these doses could not be set to achieve exactly equal effect levels, the different response curves we observed would predict different relative effects of the compounds on various proteins, in apparent conflict with the notion of a uniform response. However, by examining more sets of treatment conditions and using an overall measure of change (PCI) as a comparative index parameter, we observed that a unified response curve is probably a reasonable approximation for most proteins responding to PPÃ t present, few of the 107 protein spots we selected as relevant to the PP effect have been identified (Table t) We attempted to identify the most strongly induced of these (IEF:l63) by sequence analysis, but found the peptide sequences we obtained to be absent from current sequence databases. This is somewhat surprising, since it suggests that one of the most strongly induced elements of the PP effect is likely to be an unknown protein. Recent progress in microanalytical methods, both chemical and mass spectrometric, give us reason to expect that most will be identified (or else found to be novel, then cloned and sequenced) within the next few years. This information will allow us to interpret the manifold effects of PP on liver gene regulation and metabolism in a comprehensive way and in particular to see whether major biochemical aspects of the pathway have escaped notice so far.
